PCV51 ESTIMATING THE IMPACT OF MANDATORY SWITCH FROM ATORVASTATINTO SIMVASTATIN IN NORWAY
Nov 1, 2007, 00:00 AM
10.1016/S1098-3015(10)65466-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)65466-6/fulltext
Section Title :
Section Order :
624
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65466-6&doi=10.1016/S1098-3015(10)65466-6